227 related articles for article (PubMed ID: 12831324)
1. Mass spectrometry-based clinical proteomics.
Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
[TBL] [Abstract][Full Text] [Related]
2. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
4. Capillary electrophoresis-mass spectrometry for the analysis of intact proteins.
Haselberg R; de Jong GJ; Somsen GW
J Chromatogr A; 2007 Aug; 1159(1-2):81-109. PubMed ID: 17560583
[TBL] [Abstract][Full Text] [Related]
5. The Lucid Proteomics System for top-down biomarker research.
Jourdain S; Bulman A; Dalmasso E
Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
[TBL] [Abstract][Full Text] [Related]
6. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
7. Towards the application of proteomics in renal disease diagnosis.
Vidal BC; Bonventre JV; I-Hong Hsu S
Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
[TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
9. [Study on proteomics of familial systemic lupus erythematosus patients in one family from Sichuan, China].
Wu YK; Huang ZC; Shi YY; Cai B; Wang LL; Ying BW; Hu CJ; Li YZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):504-7, 512. PubMed ID: 19627015
[TBL] [Abstract][Full Text] [Related]
10. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry for rapid characterization of microorganisms.
Demirev PA; Fenselau C
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():71-93. PubMed ID: 20636075
[TBL] [Abstract][Full Text] [Related]
12. Proteomic patterns: their potential for disease diagnosis.
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
[TBL] [Abstract][Full Text] [Related]
13. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
16. Value of proteomics applied to the follow-up in stem cell transplantation.
Weissinger EM; Mischak H; Ganser A; Hertenstein B
Ann Hematol; 2006 Apr; 85(4):205-11. PubMed ID: 16463156
[TBL] [Abstract][Full Text] [Related]
17. Targeted comparative proteomics by liquid chromatography/matrix-assisted laser desorption/ionization triple-quadrupole mass spectrometry.
Melanson JE; Chisholm KA; Pinto DM
Rapid Commun Mass Spectrom; 2006; 20(5):904-10. PubMed ID: 16470697
[TBL] [Abstract][Full Text] [Related]
18. Surface-assisted laser desorption/ionization mass spectrometry.
Dattelbaum AM; Iyer S
Expert Rev Proteomics; 2006 Feb; 3(1):153-61. PubMed ID: 16445359
[TBL] [Abstract][Full Text] [Related]
19. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
20. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
